TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / MBRace Therapeutics Stock

MBRace Therapeutics Stock

www.mbracetrx.com/Healthcare / BioTech & PharmaFounded: 2020

MBrace Therapeutics is dedicated to transforming cancer treatment through innovative discovery, aiming to translate research into transformative therapies for cancer patients. The team comprises experienced experts across cancer drug development, working together to offer new and improved treatment options. MBrace's approach integrates the expertise of researchers, the needs of patients, the guidance of physicians, and the team's dedication, fostering advancements in cancer therapeutics. Each team member's personal experience with cancer underpins their commitment to patient care, driving the development of novel treatment options.

Buy or sell MBRace Therapeutics stockLearn more about MBRace Therapeutics IPO

Register To Buy and Sell Shares

For more details on financing and valuation for MBRace Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access MBRace Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like MBRace Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

MBRace Therapeutics investors also invested in these private companies

Venrock
Alta Partners
TPG
Avidity Partners
Cowen Healthcare Investments

Team

Management Team

Yongjian Wu Ph.D
Chief Development Officer & Head of CMC
Renata Pasqualini Ph.D
Co-Founder, Chief Scientific Officer & Scientific Advisor
Isan Chen MD
Co-Founder, Chief Executive Officer & President
Wadih Arap Ph.D
Co-Founder & Scientific Advisor

Board Members

Carolyn Ng Ph.D
TPG
Eric Pham Ph.D
Cowen Healthcare Investments
Mariana Mihalusova
Venrock
Monal Mehta Ph.D
Avidity Partners
Racquel Bracken
Venrock
Robert More
Alta Partners

Frequently Asked Questions About MBRace Therapeutics’ Stock

plusminus
Can you buy MBRace Therapeutics’ stock?
MBRace Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy MBRace Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell MBRace Therapeutics’ stock?
Yes, you can sell stock of a private company like MBRace Therapeutics. Forge can help you sell your MBRace Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is MBRace Therapeutics’ stock price?
MBRace Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access MBRace Therapeutics’ private market stock price with Forge Data.
plusminus
What is MBRace Therapeutics’ stock ticker symbol?
MBRace Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like MBRace Therapeutics in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

FinSMEs 11/14/2023
MBrace Therapeutics Raises $85M in Series B Financing
MBrace Therapeutics, a San Diego, CA-based biopharmaceutical company, raised $85M in Series B funding. The round, which brought the total amount to $110M, was led by TPG, investing through its dedicated life sciences fund, TPG Life Sciences Innovations (TPG LSI), and its multi-sector impact strategy, The Rise Fund. The round also included new investors Avidity Partners and Cowen Healthcare Investments, as well as existing Series A investors, Venrock and Alta Partners.

Trending Companies

Frequently Asked Questions

Updated on: Apr 27, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.